Securities · Lawsuit Filed

FMC Corporation (FMC) Investors Sue, Claiming the Company Hid a Distributor Inventory Problem

Published November 22, 2026

Investors who bought FMC Corporation common stock from February 4 through October 14, 2026 may be covered by a proposed class action alleging FMC Corporation misled investors about its 2026 outlook while distributors were struggling to sell its higher-priced crop protection products. No class has been certified and there is nothing to file yet.

A tractor in a cultivated farm field at sunrise
▼ Allegations Only · No Settlement Yet

This article describes a class action complaint. The statements below are unproven allegations. FMC Corporation and its executives have not been found liable, there is no certified class, and nothing to claim at this time. This page is informational and is not legal advice.

What Is This About?

An FMC Corporation shareholder filed a proposed securities class action against the company and two of its top executives on November 19, 2026 in the U.S. District Court for the Eastern District of Pennsylvania. The case is Godeas v. FMC Corporation, No. 2:26-cv-08831, and it has been assigned to Judge Harvey Bartle III. It is brought on behalf of investors who bought or otherwise acquired FMC common stock between February 4 and October 14, 2026.

FMC is an agricultural sciences company that sells crop protection chemicals, and its stock trades on the New York Stock Exchange under the ticker FMC. The complaint alleges that FMC gave investors a 2026 outlook, and kept standing behind it for months, without disclosing that distributors were holding higher-priced FMC products they found hard to sell, which the plaintiff says was hurting replenishment orders across FMC’s portfolio.

The case is at the complaint stage. No lead plaintiff has been appointed, no class has been certified, and there is no settlement, fund or claim form.

Status Complaint Filed filed November 19, 2026 · E.D. Pa.
Class Period Feb. 4, 2026 – Oct. 14, 2026 FMC Corporation common stock (NYSE: FMC)
Lead Plaintiff Deadline Not verified 60 days after the first published PSLRA notice · not a claim deadline
Can I Claim? No — nothing to claim yet

FMC’s 2026 Outlook

According to the complaint, FMC issued its 2026 outlook on February 4, 2026, the first day of the class period. It projected revenue of $3.60 billion to $3.80 billion, adjusted EBITDA of $670 million to $730 million, and free cash flow anywhere from negative $65 million to positive $65 million.

The complaint says FMC paired that outlook with several plans: cutting about $1 billion of debt through asset sales and licensing; lowering manufacturing costs by at least 35% by 2027 on about $1 billion of core products made in high-cost plants; a “post-patent strategy” for Rynaxypyr, an insecticide whose patent protection ended at the end of 2025, aimed at keeping branded earnings flat; and $300 million to $400 million of 2026 sales from new active ingredients.

The complaint then tracks statements FMC and its executives made over the following months: on its February 5 earnings call, at investor conferences on February 25, March 18, May 14 and June 17, and with first-quarter results on April 29–30, when FMC reaffirmed its guidance. At the June 17 conference, the complaint quotes management saying, “I don’t see any reason to change the full year.”

With second-quarter results on July 29–30, according to the complaint, FMC lowered its revenue and adjusted EBITDA ranges but raised its free cash flow outlook to $75 million to $225 million after a prepayment from Corteva. The complaint quotes chief executive Pierre R. Brondeau saying FMC had “all the reasons in the world to believe that 2026 is the trough.”

How the Numbers Changed

The table below sets out the figures as the complaint describes them. The October 14–15 figures are preliminary results for the third quarter alone; the other rows are full-year 2026 ranges.

Announced Period Revenue Adjusted EBITDA
February 4, 2026 Full-year 2026 outlook $3.60B – $3.80B $670M – $730M
July 29–30, 2026 Full-year 2026 outlook, lowered $3.50B – $3.70B $620M – $680M
October 14–15, 2026 Third quarter only, preliminary $65M – $125M negative $565M to negative $510M
October 29, 2026 Full-year 2026 outlook, cut again $2.75B – $2.85B negative $124M to negative $104M

What the Complaint Alleges Was Misleading

The plaintiff alleges that FMC’s outlook and the statements reaffirming or adjusting it were misleading because FMC was dealing with a distributor-inventory problem it did not disclose. According to the complaint, distributors were holding higher-priced FMC products that were hard to sell, and that slowed the replenishment orders FMC depended on across its product line.

FMC announced preliminary third-quarter results after the market closed on October 14, 2026, with a press release the complaint also dates October 15. As the complaint describes them, the results showed revenue of $65 million to $125 million and adjusted EBITDA of negative $565 million to negative $510 million. FMC attributed the shortfall to distributors seeking the lowest possible inventory levels and to higher-priced FMC products sitting in channel inventory, and it cited a negative impact of about $625 million to $675 million from commercial actions. The complaint quotes Brondeau saying, “We have addressed this issue incrementally over several quarters, but under current market conditions, we determined that more comprehensive actions are necessary.”

The Stock Drop

According to the complaint, FMC stock fell from an $8.09 close on October 14, 2026 to $5.62 on October 15, a drop of about 31%. The complaint says FMC had about 155.5 million shares outstanding as of September 30, 2026.

When FMC reported its full third-quarter results on October 29, 2026, the complaint says, it put the negative impact of the commercial actions, which addressed channel inventory and changed its North American pricing and rebate model, at $639 million. It also cut its full-year 2026 outlook to revenue of $2.75 billion to $2.85 billion, adjusted EBITDA of negative $124 million to negative $104 million, and adjusted earnings per share of negative $3.66 to negative $3.50.

Who Is Being Sued and Under Which Laws

The defendants are FMC; Pierre R. Brondeau, its chief executive and board chair; and Andrew D. Sandifer, its executive vice president and chief financial officer. The complaint asserts two claims:
A Section 10(b) claim generally requires a plaintiff to prove that a defendant made a materially false or misleading statement with intent to mislead or reckless disregard for the truth, and that the statement caused investors’ losses. The complaint demands a jury trial. None of the allegations has been tested in court.

Who Is in the Proposed Class?

The proposed class is everyone who purchased or otherwise acquired FMC common stock between February 4, 2026 and October 14, 2026, inclusive, and was damaged as a result. The class exists only as a proposal until a court certifies it, and its definition can change as the case proceeds.

What Happens Next

The Private Securities Litigation Reform Act requires notice of a new securities class action to be published, and any member of the proposed class may then ask the court, within 60 days after that first published notice, to be appointed lead plaintiff. Law firms have publicized a date for the FMC case, but OpenClassActions.com had not verified it from the notice itself as of November 22, 2026. Members of a proposed securities class generally remain in the class without seeking the lead plaintiff role. After the court picks a lead plaintiff and lead counsel, an amended complaint usually follows, and defendants typically move to dismiss.

The complaint was filed by Pribanic & Pribanic, LLC and Levi & Korsinsky LLP. On the day it was filed, the court entered its standard notices on consent to a magistrate judge and on court-annexed mediation. As of November 22, 2026, the docket showed no response from FMC, Brondeau or Sandifer. There is no money available unless the case produces a settlement or judgment, which would come with its own notice and claim process.

Questions

Who is covered by the FMC Corporation securities class action?

The proposed class is everyone who purchased or otherwise acquired FMC Corporation common stock between February 4, 2026 and October 14, 2026, inclusive, and was damaged. No class has been certified, and the definition can change as the case proceeds.

What does the FMC lawsuit claim was misleading?

The complaint alleges that FMC’s 2026 outlook and later statements reaffirming or adjusting it were misleading because distributors were holding higher-priced FMC products they found hard to sell, which the plaintiff says was hurting replenishment orders across FMC’s portfolio. FMC has not been found liable.

When is the lead plaintiff deadline in the FMC case?

The Private Securities Litigation Reform Act lets class members ask to be appointed lead plaintiff within 60 days after the first published notice of the case. OpenClassActions.com had not verified the FMC date from that notice as of November 22, 2026. The lead plaintiff deadline is not a claim deadline, and class members generally remain in the proposed class without seeking that role.

Is there an FMC settlement to claim?

There is no settlement, fund or claim form. The case was filed on November 19, 2026, no lead plaintiff has been appointed and no class has been certified. Money would become available only through a settlement or judgment, which would come with its own court-approved notice and claim process.

Sources


For more class actions keep scrolling below.
Status Complaint Filed
Case Title Godeas v. FMC Corporation
Case Number 2:26-cv-08831
Court U.S. District Court, Eastern District of Pennsylvania
Date Filed November 19, 2026
Ticker NYSE: FMC
Official Website Court Docket (CourtListener)

More Securities Class Actions